1 August 2022 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
5 December 2024 in Journal of Interventional Cardiac Electrophysiology
9 May 2025 in International Journal of Cardiology Cardiovascular Risk and Prevention
The impact of metabolic risk factors on ischemic heart disease (IHD) exhibits substantial regional variability. This study aims to analyze three-decade mortality trends in two contrasting regions of North America (NA) and South Asia (SA), focusing on age- and gender-specific variations. Data from the Global Burden of Disease (GBD) database [1990–2021] were employed in Joinpoint Regression Program to compute the Annual Percent Changes (APC) and Average Annual Percent Changes (AAPC). Mortality rate trends were disaggregated by age and gender and subsequently compared both within and between the NA and SA populations, with statistical significance set at P < 0.05. Results were graphically represented, with mortality rates per 100,000 on the y-axis and years on the x-axis. An overall decline in mortality rates was noted in NA, whereas SA displayed an overall increase. Age-specific stratification revealed that older adults in NA had a higher baseline mortality rate and experienced a more pronounced decline compared to younger adults. In contrast, older adults in SA exhibited a significant increase in mortality rates, whereas younger adults showed no significant change. Gender-specific analysis indicated substantial reductions in mortality rates for both males and females in NA, while SA males demonstrated a sharper increase, and SA females experienced no significant change. Our study revealed divergent trends in metabolic risk factor-related IHD mortality between NA and SA, with significant variations observed across age and gender groups emphasizing the necessity of investigating the socioeconomic, environmental, and genetic determinants driving these disparities.
20 November 2025 in Angiology
Carotid artery stenting (CAS) is an established alternative to endarterectomy, but stent fracture is an under-recognized complication with potential clinical consequences. We report a case of carotid stent fracture in a 69-year-old male with prior neck radiation, presenting with severe in-stent restenosis 10 months post-stenting. To place this case in context, a systematic review of PubMed, Embase, and Scopus (through June 2025) was conducted in line with PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines. Ten retrospective studies (2365 patients) were included. Stent fracture was identified in 172 patients, with a pooled prevalence of 7.3%. Type I and II fractures were most common, while Type V was rare. Reported risk factors included prior neck irradiation, vessel tortuosity, long stent length, and closed-cell stent design. Fluoroscopy was the most reliable detection method. Restenosis rates varied widely (0%-36%), most patients remained asymptomatic and were managed conservatively. In conclusion, Carotid stent fracture occurs in approximately 7% of cases and is often clinically silent, though it may predispose to restenosis. Surveillance and management should be individualized, with intervention reserved for symptomatic patients or progressive disease.